Cell-based analysis of <i>CAD</i> variants identifies individuals likely to benefit from uridine therapy

Francisco del Caño‐Ochoa(Instituto de Salud Carlos III), Santiago Ramón‐Maiques(Instituto de Biomedicina de Valencia)

bioRxiv (Cold Spring Harbor Laboratory)

March 12, 2020

10.1101/2020.03.11.987651

Cited by 1

Related Papers

Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy

|Genetics in Medicine|2020|27